(Q37157505)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18464748%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

review article

1 reference

title

Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18464748%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

main subject

cardiovascular disease

1 reference

Speranza Donatella Rubattu

inferred from title

author

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18464748%20AND%20SRC:MED&resulttype=core&format=json

Speranza Donatella Rubattu

7 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18464748%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Sebastiano Sciarretta

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18464748%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Rosita Stanzione

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18464748%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Massimo Volpe

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18464748%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

4

Valentina Valenti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18464748%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

8 May 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18464748%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Hypertension

7 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18464748%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18464748%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18464748%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

733-741

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18464748%20AND%20SRC:MED&resulttype=core&format=json

A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats

7 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Which of the cardiac natriuretic peptides is most effective for the treatment of congestive heart failure, renal failure and cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

C-type natriuretic peptide in vascular physiology and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Interactions between the sympathetic nervous system and the cardiac natriuretic peptide system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Physiological concentration of atrial natriuretic peptide induces endothelial regeneration in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Atrial natriuretic peptide inhibits the production of adipokines and cytokines linked to inflammation and insulin resistance in human subcutaneous adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Increased Atherosclerosis and Smooth Muscle Cell Hypertrophy in Natriuretic Peptide Receptor A −/− Apolipoprotein E −/− Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Cardiac fibrosis in mice lacking brain natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Effects of intravenously administered C-type natriuretic peptide in humans: comparison with atrial natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Potential of gene therapy strategy for the treatment of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Human atrial natriuretic peptide gene delivery reduces blood pressure in hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Regulatable atrial natriuretic peptide gene therapy for hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Vasopeptidase inhibitors: a new therapeutic concept in cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Omapatrilat versus lisinopril: efficacy and neurohormonal profile in salt-sensitive hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Atrial natriuretic peptide inhibits cardiomyocyte hypertrophy through mitogen-activated protein kinase phosphatase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Metabolic syndrome and target organ damage in untreated essential hypertensives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Impact of obesity on plasma natriuretic peptide levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Novel snake venom ligand dendroaspis natriuretic peptide is selective for natriuretic peptide receptor-A in human heart: downregulation of natriuretic peptide receptor-A in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Direct inhibition of neutral endopeptidase in vasopeptidase inhibitor-mediated amelioration of cardiac remodeling in rats with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity and left ventricular remodeling in patients with first anterior acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Inhibitory effect of C-type natriuretic peptide (CNP) on cultured cardiac myocyte hypertrophy: interference between CNP and endothelin-1 signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Cross-sectional relations of multiple biomarkers from distinct biological pathways to brachial artery endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Natriuretic peptides and mortality after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Plasma natriuretic peptide levels and the risk of cardiovascular events and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Atrial natriuretic peptide gene polymorphisms and risk of ischemic stroke in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Angiotensin II stimulates and atrial natriuretic peptide inhibits human visceral adipocyte growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Insulin stimulates glucose transport via nitric oxide/cyclic GMP pathway in human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Atrial natriuretic peptide inhibits tumor necrosis factor-alpha production by interferon-gamma-activated macrophages via suppression of p38 mitogen-activated protein kinase and nuclear factor-kappa B activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Inhibition of cyclooxygenase-2 by natriuretic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Anoxia/reoxygenation-induced leukocyte-endothelial cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Pharmacological potentiation of natriuretic peptide limits polymorphonuclear neutrophil-vascular cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Local expression of C-type natriuretic peptide suppresses inflammation, eliminates shear stress-induced thrombosis, and prevents neointima formation through enhanced nitric oxide production in rabbit injured carotid arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Effect of neutral endopeptidase inhibitor on endogenous atrial natriuretic peptide as a paracrine factor in cultured cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-beta in primary human cardiac fibroblasts: fibrosis, myofibroblast conversion, proliferation, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Gene Expression, Secretion, and Autocrine Action of C-Type Natriuretic Peptide in Cultured Adult Rat Cardiac Fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Heart failure: a state of brain natriuretic peptide deficiency or resistance or both!

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

B-type natriuretic peptide predicts sudden death in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Myocardial production of C-type natriuretic peptide in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

Amino-terminal pro-C-type natriuretic peptide in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

7 January 2021

Biochemistry of natriuretic peptides

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

7 January 2021

Atrial Natriuretic Peptide Has Different Effects on Contractility and Intracellular pH in Normal and Hypertrophied Myocytes From Pressure-Overloaded Hearts

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

7 January 2021

Atrial natriuretic peptide elevation in congestive heart failure in the human

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

7 January 2021

Four-hour infusions of synthetic atrial natriuretic peptide in normal volunteers

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

7 January 2021

Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

7 January 2021

Atrial natriuretic peptide (ANP) gene promoter variant and increased susceptibility to early development of hypertension in humans

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

7 January 2021

Prolonged low dose infusion of atrial natriuretic factor in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

7 January 2021

Hormonal and renal effects of atrial natriuretic peptide in patients with secondary hypertension

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

7 January 2021

Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

7 January 2021

Opposing effects of Jun kinase and p38 mitogen-activated protein kinases on cardiomyocyte hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

7 January 2021

Local Atrial Natriuretic Peptide Signaling Prevents Hypertensive Cardiac Hypertrophy in Endothelial Nitric-oxide Synthase-deficient Mice

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

7 January 2021

Antioxidant actions contribute to the antihypertrophic effects of atrial natriuretic peptide in neonatal rat cardiomyocytes

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

7 January 2021

Functional deletion mutation of the 5'-flanking region of type A human natriuretic peptide receptor gene and its association with essential hypertension and left ventricular hypertrophy in the Japanese

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

7 January 2021

Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

7 January 2021

Vasopeptidase inhibition with omapatrilat improves cardiac geometry and survival in cardiomyopathic hamsters more than does ACE inhibition with captopril

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

7 January 2021

C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

7 January 2021

Altered structure, regulation, and function of the gene encoding the atrial natriuretic peptide in the stroke-prone spontaneously hypertensive rat

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

7 January 2021

The gene encoding atrial natriuretic peptide and the risk of human stroke

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

7 January 2021

Association of the ScaI atrial natriuretic peptide gene polymorphism with nonfatal myocardial infarction and extent of coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

7 January 2021

C-type natriuretic peptide-induced vasodilation is dependent on hyperpolarization in human forearm resistance vessels

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

7 January 2021

Mechanisms of natriuretic-peptide-induced growth inhibition of vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

7 January 2021

C-type natriuretic peptide inhibits intimal thickening after vascular injury

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

7 January 2021

Induction of IκB: atrial natriuretic peptide as a regulator of the NF-κB pathway

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

7 January 2021

Autocrine regulation of inducible nitric-oxide synthase in macrophages by atrial natriuretic peptide

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

7 January 2021

Atrial natriuretic peptide inhibits transforming growth factor beta-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

7 January 2021

Markers of Inflammation and Fibrosis Are Related to Cardiovascular Damage in Hypertensive Patients with Metabolic Syndrome

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.174

7 January 2021

https://api.crossref.org/works/10.1038%2FAJH.2008.174

1 reference

7 January 2021

Identifiers

DOI

10.1038/AJH.2008.174

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18464748%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference